The disclosure provides processes for synthesizing compounds for use as CFTR modulators. ##STR00001##

The disclosure provides processes for synthesizing compounds for use as CFTR modulators. ##STR00001##

Provided is an ibuprofen ester prodrug represented by Structural Formula (1), a racemate, stereoisomer or pharmaceutically acceptable salt or solvate thereof, or a solvate of a pharmaceutically acceptable salt thereof. Further provided are a method for preparing the compound, a pharmaceutical composition containing the compound, and an application of the compound in preparation of nonsteroidal anti-inflammatory drugs. The pharmaceutical composition containing the ibuprofen ester prodrug may be prepared into fat emulsion injection preparations. The ibuprofen ester prodrug has good stability and good pharmacokinetic properties and overcomes the problems of ibuprofen such as a short half-life, poor stability, irritation, and incompatibility.

##STR00001##

Provided is an ibuprofen ester prodrug represented by Structural Formula (1), a racemate, stereoisomer or pharmaceutically acceptable salt or solvate thereof, or a solvate of a pharmaceutically acceptable salt thereof. Further provided are a method for preparing the compound, a pharmaceutical composition containing the compound, and an application of the compound in preparation of nonsteroidal anti-inflammatory drugs. The pharmaceutical composition containing the ibuprofen ester prodrug may be prepared into fat emulsion injection preparations. The ibuprofen ester prodrug has good stability and good pharmacokinetic properties and overcomes the problems of ibuprofen such as a short half-life, poor stability, irritation, and incompatibility.

##STR00001##

The present invention relates to the technical field of chemical engineering, and in particular to a linear carbonate and a preparation method thereof, which includes one or more of compounds of structural formula 1 below:

##STR00001##

wherein R.sub.1 and R.sub.2 are respectively selected from one of alkyl groups containing 1˜4 carbon atoms;

a hydroxyl concentration of the linear carbonate is no more than 100 ppm, and a free acid conversion rate of a solution with a concentration of 1 mol/L as formulated from the linear carbonate and lithium hexafluorophosphate is less than 1.2 after storage under 25° C. for 30 days. An acidity conversion rate was reduced when lithium hexafluorophosphate is dissolved in the linear carbonate by controlling the hydroxyl concentration, the energy density, discharge capacity, safety performance and service life of a battery can be improved when it's electrolyte solution contains the linear carbonate.

A process prepares glycerol carbonate (meth)acrylate by transesterification of methyl (meth)acrylate with glycerol carbonate, in the presence of a zirconium acetylacetonate catalyst. The catalyst is pretreated with 2% by weight to 25% by weight of water, based on the amount of catalyst.

A process prepares glycerol carbonate (meth)acrylate by transesterification of methyl (meth)acrylate with glycerol carbonate, in the presence of a zirconium acetylacetonate catalyst. The catalyst is pretreated with 2% by weight to 25% by weight of water, based on the amount of catalyst.

The invention relates to a process wherein a dialkyl carbonate stream containing an ether alkanol impurity is subjected to extractive distillation using an extraction solvent to obtain a top stream comprising dialkyl carbonate and a bottom stream comprising the ether alkanol impurity and the extraction solvent, wherein the extraction solvent is an organic compound containing one or more ester moieties and/or ether moieties which organic compound does not contain a hydroxyl group. Further, the invention relates to a process for making a diaryl carbonate, comprising reacting an aryl alcohol with a stream containing a dialkyl carbonate from which stream an ether alkanol impurity has been removed in accordance with the above-described process.

The invention relates to a process wherein a dialkyl carbonate stream containing an ether alkanol impurity is subjected to extractive distillation using an extraction solvent to obtain a top stream comprising dialkyl carbonate and a bottom stream comprising the ether alkanol impurity and the extraction solvent, wherein the extraction solvent is an organic compound containing one or more ester moieties and/or ether moieties which organic compound does not contain a hydroxyl group. Further, the invention relates to a process for making a diaryl carbonate, comprising reacting an aryl alcohol with a stream containing a dialkyl carbonate from which stream an ether alkanol impurity has been removed in accordance with the above-described process.

The application related to an ibuprofen ester derivative and an emulsion preparation thereof. A carboxyl group of racemic ibuprofen or S-ibuprofen is derivatized so that Compound N9 and a dextrorotatory enantiomer N9(S) thereof are obtained and further prepared into an emulsion preparation, which overcomes the problems of safety and compliance of patients existing in clinical application of existing ibuprofen/dexibuprofen injections and achieves the purposes of reducing vascular irritation, increasing clinical use approaches, and improving the stability of preparations in clinical applications.